Newfound Research LLC Buys Shares of 256 West Pharmaceutical Services, Inc. (NYSE:WST)

Newfound Research LLC bought a new stake in West Pharmaceutical Services, Inc. (NYSE:WSTGet Rating) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 256 shares of the medical instruments supplier’s stock, valued at approximately $77,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in WST. American International Group Inc. lifted its holdings in West Pharmaceutical Services by 0.3% in the 4th quarter. American International Group Inc. now owns 23,223 shares of the medical instruments supplier’s stock valued at $10,892,000 after purchasing an additional 59 shares in the last quarter. Fiduciary Trust Co. lifted its holdings in West Pharmaceutical Services by 8.0% in the 4th quarter. Fiduciary Trust Co. now owns 713 shares of the medical instruments supplier’s stock valued at $334,000 after purchasing an additional 53 shares in the last quarter. Gotham Asset Management LLC lifted its holdings in shares of West Pharmaceutical Services by 93.3% during the 4th quarter. Gotham Asset Management LLC now owns 1,260 shares of the medical instruments supplier’s stock worth $591,000 after acquiring an additional 608 shares during the period. Siemens Fonds Invest GmbH lifted its holdings in shares of West Pharmaceutical Services by 28.8% during the 4th quarter. Siemens Fonds Invest GmbH now owns 1,006 shares of the medical instruments supplier’s stock worth $474,000 after acquiring an additional 225 shares during the period. Finally, Nissay Asset Management Corp Japan ADV lifted its holdings in shares of West Pharmaceutical Services by 1.8% during the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 13,973 shares of the medical instruments supplier’s stock worth $6,553,000 after acquiring an additional 250 shares during the period. 91.98% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at West Pharmaceutical Services

In related news, insider Silji Abraham sold 5,374 shares of the stock in a transaction that occurred on Monday, August 1st. The shares were sold at an average price of $343.93, for a total transaction of $1,848,279.82. Following the completion of the sale, the insider now owns 3,201 shares of the company’s stock, valued at approximately $1,100,919.93. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.60% of the company’s stock.

West Pharmaceutical Services Trading Down 1.0 %

Shares of WST stock traded down $2.60 during trading hours on Friday, hitting $250.51. 7,046 shares of the company were exchanged, compared to its average volume of 370,337. The firm has a market cap of $18.55 billion, a PE ratio of 28.09, a PEG ratio of 1.04 and a beta of 1.18. West Pharmaceutical Services, Inc. has a 1 year low of $251.69 and a 1 year high of $475.00. The company has a quick ratio of 2.41, a current ratio of 3.13 and a debt-to-equity ratio of 0.09. The firm has a fifty day moving average of $310.21 and a 200 day moving average of $328.46.

West Pharmaceutical Services (NYSE:WSTGet Rating) last announced its quarterly earnings data on Thursday, July 28th. The medical instruments supplier reported $2.47 earnings per share for the quarter, topping the consensus estimate of $2.19 by $0.28. The business had revenue of $771.30 million for the quarter, compared to analyst estimates of $754.25 million. West Pharmaceutical Services had a net margin of 23.41% and a return on equity of 29.08%. The company’s revenue was up 6.6% on a year-over-year basis. During the same period in the prior year, the firm posted $2.46 EPS. Analysts expect that West Pharmaceutical Services, Inc. will post 9.09 earnings per share for the current year.

About West Pharmaceutical Services

(Get Rating)

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.

Featured Stories

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WSTGet Rating).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.